GabuzdaDHHirschMS. Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. Ann Intern Med1987; 107: 383–91
2.
LevyRMBredesdenDERosenblumML. Neurologic manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. J Neurosurg1985; 62: 475–95
3.
SniderWDSimpsonDMNielsenSGoldJWMMetrokaCEPosnerJB. Neurologic complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol1983; 14: 403–18
4.
KovacsJAKovacsAAPolisM. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med1985; 103: 533–8.
5.
ZugerALouieEHolzmanRSSimberkoffMSRahalJJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med1986; 104: 234–40
6.
EngRHKBishburgESmithSMKapilaR.Cryptococcal infection in patients with acquired immune deficiency syndrome. Am J Med1986; 81: 19–23
7.
DismukesWE. Cryptococcal meningitis in patients with AIDS. J Infect Dis1988; 157: 624–8
8.
LevyRMJanssenRSBushTJRosenblumML. Neuro-epidemiology of acquired immunodeficiency syndrome. J AIDS1988; 1: 31–40
9.
ChuckSSandeM.Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med1989; 321: 794–9
10.
WeinkeTRoglerGSixtC. Cryptococcosis in AIDS patients; observations concerning CNS involvement. J Neurol1989; 236: 38–42
11.
ClarkRAGreerDAtkinsonWValainisGTHyslopN.Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis1990; 12: 768–77
12.
NelsonMRBowerMSmithDReedCShansonDGazzardB.The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus. J Infect1990; 21: 175–81
13.
BergmanF.Occurrence of Cryptococcus neoformans in Sweden. Acta Med Scand1963; 174: 651–5
14.
EmmonsCW. Prevalence of Cryptococcus neoformans in pigeon habitats. Public Health Rep1960; 75: 362–4
15.
Kwon-ChungKJVarmaAHowardDH. Ecology of Cryptococcus neoformans and prevalence of its two varieties in AIDS and non-AIDS associated cryptococcosis. In: BosscheH VandenMackenzieDWRCauwenberghGVan CutsemJDrouhetEDupontB. eds. Mycoses in AIDS patients. New York: Plenum Press, 1990:103–13
16.
McCauleyDINaidichDPLeitmanBSReedeDLLaubensteinL.Radiographic patterns of opportunistic lung infections and Kaposi's sarcoma in homosexual men. AJR Am J Roentgenol1982; 139: 653–8
17.
MurrayJFFeltonCPGaraySM. Pulmonary complications of the acquired immunodeficiency syndrome: Report of a National Heart, Lung and Blood Institute workshop. N Engl J Med1984; 310: 1682–8
18.
CohenBAPomeranzSRabinowitzJG. Pulmonary complications of AIDS: Radiographic features. AJR1984; 143: 115–22
19.
HollermanJJBernsteinMABeuteGH. Thoracic manifestations of AIDS. Am Fam Physician1987; 35: 109–18
20.
GalAAKossMNHawkinsJEvansSEinsteinH.The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med1986; 110: 502–7
21.
ChechaniVKamholzSL. Pulmonary manifestations of disseminated cryptococcosis in patients with AIDS. Chest1990; 98: 1060–6
22.
CameronMLBartlettJAGallisHAWaskinHA. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis1991; 13: 64–7
LarsenRABozzetteSMcCutchanJAChiuJLealMARichmanDD. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Intern Med1989; 111: 125–8
25.
San FeliceF.Contributo alla morfologica e biologica dei blastomiceti che si sviluppano nei succhi di alcuni frutti. Ann Ig Sperimentale1894; 5: 239–62
26.
ShaunakSSchellWAPerfectJR. Cryptococcal meningitis with normal cerebrospinal fluid. J Infect Dis1989; 160: 912
27.
HauptHMMerzWGBerschornerWE. Colonization and infection with trichosporon species in the immunosuppressed host. J Infect Dis1983; 147: 199
28.
KozelTR. Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect Immun1977; 16: 99–106
29.
GalAAEvansSMeyerPR. The clinical and laboratory evaluation of cryptococcal infections in the acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis1987; 7: 249–54
30.
KhouryMBGodwinJDRavinCEGallisHAHalvorsenRAPutmanCE. Thoracic cryptococcosis: Immunologic competence and radiologic appearance. AJR Am J Roentgenol1984; 142: 893–6
31.
WasserLTalaveraW.Pulmonary cryptococcosis in AIDS. Chest1987; 92: 692–5
32.
MillerWTEdelmanJMillerW.Cryptococcal pulmonary infection in patients with AIDS: Radiographic appearance. Radiology1990; 175: 725–8
33.
PostMJDSheldonJJHensleyGT. Central nervous system disease in acquired immunodeficiency syndrome: Prospective correlation using CT, MR imaging, and pathologic studies. Radiology1986; 158: 141–8
34.
ElkinCMLeonEGrenellSLLeedsNE. Intracranial lesions in the acquired immunodeficiency syndrome. Radiological (computed tomographic) features. JAMA1985; 253: 393–6
35.
PopovichMJArthurRHHelmerE.CT of intracranial cryptococcosis. AJR Am J Roentgenol1990; 154: 603–6
36.
LarsenRALealMAChanLS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med1990; 113: 183–7
37.
MillerMFMitchellTG. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun1991; 59: 24–8
38.
BennettJEDismukesWEDumaRJ. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med1979; 301: 126–31
39.
DiamondRDBennettJE. Prognostic factors in cryptococcal meningitis: A study in 111 cases. Ann Intern Med1974; 80: 176–81
40.
KaplanMHRosenPPArmstrongD.Cryptococcosis in a cancer hospital: Clinical and pathological correlates in forty-six patients. Cancer1977; 39: 2265–74
41.
DismukesWECloudGGallisHA. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med1987; 317: 334–41
42.
ButlerWTBennettJEAilingDWWertlakePTUtzJPHillGJIII. Nephrotoxicity of amphotericin B: Early and late effects in 81 patients. Ann Intern Med1964; 61: 175–87
43.
ShaunakSCohenJ.Clinical management of fungal infection in patients with AIDS. J Antimicrob Chemother1991; 28:(suppl A): 67–81
44.
StammAMDiasioRBDismukesWE. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med1987; 83: 236–42
45.
CokerRTomlinsonDHarrisJ.Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin B. AIDS1991; 5: 231–2
46.
SchurmannDde Matos MarquesBGrunewaldTPohleHDHahnHRufB.Safety and efficacy of liposomal amphotericin B in treating AIDS-associated disseminated cryptococcosis. J Infect Dis1991; 164: 620–2
47.
CokerRJMurphySMHarrisJRW. Experience with liposomal amphotericin B (AmBisome) in cryptococcal meningitis in AIDS. J Antimicrob Chemother1991; 28 (suppl B): 105–9
48.
CokerRJHornerPJ. Short course treatment and response to liposomal amphotericin B in AIDS-associated cryptococcosis. J Infect Dis1992; 165: 593
49.
JacobsonMAGellermannHChambersH.Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med1988; 85: 172–6
50.
DupontBDrouhetE.Cryptococcal meningitis and fluconazole. Ann Intern Med1987; 106: 778
51.
PerfectJRDurackDT. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother1985; 16: 81–6
52.
ArndtCASWalshTJMcCullyCLBalisFMPizzoPAPoplackDG. Fluconazole penetration into cerebrospinal fluid: Implications for treating fungal infections of the central nervous system. J Infect Dis1988; 157: 178–80
53.
TuckerRMWilliamsPLArathoonEGLevineBEHartsteinAIHansonLHStevensDA. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother1988; 32: 369–73
54.
OddsFC. Laboratory tests for the activity of imidazole and triazole antifungal agents in vitro. Semin Dermatol1985; 4: 260–70
55.
CokerRJHarrisJRW. Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels. J Infect1991; 23: 101–3
56.
GalgianiJN. Fluconazole, a new antifungal agent. Ann Intern Med1990; 113: 177–9
57.
BozzetteSALarsenRAChiuJ. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann Intern Med1991; 115: 285–6
58.
DenningDWTuckerRMHansonLHHamiltonJRStevensDA. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med1989; 149: 2301
59.
SugarAMAlsipSGGalgianiJN. Pharmacology and toxicity of high-dose ketoconazole. Antimicrob Agents Chemother1987; 31: 1874–8
60.
Lake-BazaarGTomWLake-BazaarD. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med1988; 109: 471–3
61.
VivianiMATortoranoAMLangerM. Experience with itraconazole in cryptococcosis and aspergillosis. J Infect1989; 18: 151–65
62.
de GansJSchattenkerkJKM Eeftinckvan KetelRJ. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome. BMJ1988; 296: 339
63.
van't WoutJWde Graef-MeederERPaulLCKuisWvan FurthR.Treatment of two cases of cryptococcal meningitis with fluconazole. Scand J Infect Dis1988; 20: 193–8
64.
CokerRJMoulopolosDMainJMurphyMPinchingAJHarrisJRW. Cryptococcal meningitis in AIDS occurring despite systemic antifungal therapy. J Infect1992; 23: 107
65.
NightingaleSDCalSXPetersonDM. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS1992; 6: 191–4
